A comprehensive view of Clinical Trials. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Transformation & Innovation Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
CARsgen Therapeutics partners with Roche to assess CARsgen's investigational drug AB011 combined with Roche’s atezolizumab, standard-of-care chemotherapy to treat gastric or gastroesophageal junction cancer; Roche to handle operations, clinical trial
Published:
February 01, 2023
by MarketLine
|
Gerresheimer presents its new Clinical Trial Kit at Pharmapack in Paris; kit consists of sterile Gx RTF vials in nest and tub or tray with matching closures, is tailored for the development of new drugs, vaccines and biologics in early phases
Published:
February 01, 2023
by Gerresheimer AG
|
Rise Therapeutics Announces FDA Clearance of its IND Application to Initiate a Phase 1 Study of an Oral Immunotherapy for the Treatment of Ulcerative Colitis
Published:
January 31, 2023
by PR Newswire
|
Arcturus Therapeutics announces clinical trial application for ARCT-032 to treat cystic fibrosis received approval to proceed into first-in-human studies in New Zealand; ARCT-032 is an inhaled investigational mRNA medicine
Published:
January 31, 2023
by Business Wire
|
Patent Issued for 2-azaspiro[3.4]octane derivatives as M4 agonists (USPTO 11548865)
Published:
January 31, 2023
by Clinical Trials Daily
|
Ask us about our Transformation & Innovation market view
Trending Chart
Interactive chart with headline count